IGC Pharma, Inc.IGCNYSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank53
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-5.34M
↑ 30% vs avg
Percentile
P53
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-7.58M
Historical baseline
PeriodValueYoY Change
TTM$-5.34M+25.0%
2025$-7.12M+45.2%
2024$-13.00M-13.0%
2023$-11.51M+23.4%
2022$-15.02M-70.4%
2021$-8.81M-20.5%
2020$-7.32M-78.6%
2019$-4.09M-129.3%
2018$-1.79M+2.8%
2017$-1.84M-